Publications by authors named "Robert L Camp"

79Publications

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma.

Oncotarget 2014 Jul;5(14):5209-17

Yale Cancer Center, Yale University School of Medicine, New Haven, CT, U.S.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170640PMC
http://dx.doi.org/10.18632/oncotarget.2101DOI Listing
July 2014

Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma.

Cancer Cell Int 2014 Jan 14;14(1). Epub 2014 Jan 14.

Departments of Medicine, Section of Medical Oncology, Yale University School of Medicine, 333 Cedar St., WWW213, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1475-2867-14-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896780PMC
January 2014

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors.

BMC Clin Pathol 2013 Feb 1;13. Epub 2013 Feb 1.

Department of Medicine and Yale Cancer Center, 333 Cedar St,, WWW213, New Haven, CT, 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6890-13-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575219PMC
February 2013

Vascularity of primary and metastatic renal cell carcinoma specimens.

J Transl Med 2013 Jan 14;11:15. Epub 2013 Jan 14.

Department of the School of Medicine, Yale University School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-11-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561185PMC
January 2013

CD70 expression patterns in renal cell carcinoma.

Hum Pathol 2012 Sep 7;43(9):1394-9. Epub 2012 Mar 7.

Department of Medicine, Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2011.10.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374042PMC
September 2012

Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome.

Clin Cancer Res 2012 Jan 11;18(2):370-9. Epub 2011 Nov 11.

Departments of Dermatology and Pathology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-1282DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825867PMC
January 2012

Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts.

Breast Cancer Res 2011 Nov 2;13(5):R85. Epub 2011 Nov 2.

Yale University School of Medicine, Department of Pathology, 310 Cedar St, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2937DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262195PMC
November 2011

Lymph node ratio should be considered for incorporation into staging for breast cancer.

Ann Surg Oncol 2011 Oct 17;18(11):3143-8. Epub 2011 Aug 17.

Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-011-2012-9DOI Listing
October 2011

Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanoma.

Clin Cancer Res 2010 Dec;16(24):6029-39

Department of Pathology, Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058635PMC
December 2010

Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models.

Breast Cancer Res 2010 1;12(5):R66. Epub 2010 Sep 1.

Department of Cell Biology, New York University Center for Health Informatics and Bioinformatics, New York University School of Medicine and Cancer Institute, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2633DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096952PMC
February 2013

Automated analysis of tissue microarrays.

Methods Mol Biol 2010 ;664:151-62

HistoRx, Inc, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-60761-806-5_15DOI Listing
December 2010

In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.

Am J Pathol 2010 May 12;176(5):2131-8. Epub 2010 Mar 12.

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520-8023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/ajpath.2010.090712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861079PMC
May 2010

Melanoma prognostic model using tissue microarrays and genetic algorithms.

J Clin Oncol 2009 Dec 2;27(34):5772-80. Epub 2009 Nov 2.

Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.22.8239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792999PMC
December 2009

C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.

Clin Cancer Res 2009 Sep 8;15(18):5704-13. Epub 2009 Sep 8.

Yale Cancer Center and Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-0198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763114PMC
September 2009

Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.

Clin Cancer Res 2009 May 21;15(9):3029-36. Epub 2009 Apr 21.

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2768DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431617PMC
May 2009

AQUA analysis of thymidylate synthase reveals localization to be a key prognostic biomarker in 2 large cohorts of colorectal carcinoma.

Arch Pathol Lab Med 2008 Nov;132(11):1746-52

Department of Pathology, Yale University, New Haven, CT 06511, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165-132.11.1746DOI Listing
November 2008

A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.

J Clin Oncol 2008 Dec 20;26(34):5630-7. Epub 2008 Oct 20.

Department of Pathology, Yale University School of Medicine, 310 Cedar St, PO Box 208023, New Haven, CT 06520-8023, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2008.17.3567
Publisher Site
http://dx.doi.org/10.1200/JCO.2008.17.3567DOI Listing
December 2008

Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer.

Clin Cancer Res 2008 Jul;14(14):4455-62

Department of Medicine and Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-5268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849429PMC
July 2008

Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cells.

Lab Invest 2008 Sep 14;88(9):962-72. Epub 2008 Jul 14.

Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/labinvest200865
Publisher Site
http://dx.doi.org/10.1038/labinvest.2008.65DOI Listing
September 2008

Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.

Breast Cancer Res 2008 23;10(2):R35. Epub 2008 Apr 23.

Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1998DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397537PMC
July 2008

High HSP90 expression is associated with decreased survival in breast cancer.

Cancer Res 2007 Apr;67(7):2932-7

Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-4511DOI Listing
April 2007

Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome.

Cancer Invest 2007 Feb;25(1):19-26

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900601128825DOI Listing
February 2007

Quantitative analysis of estrogen receptor heterogeneity in breast cancer.

Lab Invest 2007 Jul 5;87(7):662-9. Epub 2007 Mar 5.

Medical Oncology, Yale Cancer Center, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/labinvest.3700543DOI Listing
July 2007

Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model.

Lab Invest 2007 Mar 29;87(3):251-60. Epub 2007 Jan 29.

Department of Pathology, Yale University School of Medicine, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/labinvest.3700515DOI Listing
March 2007

Classification of breast cancer using genetic algorithms and tissue microarrays.

Clin Cancer Res 2006 Nov;12(21):6459-68

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520-8023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1383DOI Listing
November 2006

Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome.

Cancer Res 2006 May;66(10):5487-94

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-0100DOI Listing
May 2006

Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.

Cancer 2006 Apr;106(8):1677-84

Yale Cancer Center and Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21783DOI Listing
April 2006

Utility of molecular genetic signatures in the delineation of gastric neoplasia.

Cancer 2006 Apr;106(7):1480-8

Department of Surgery, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21758DOI Listing
April 2006

Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.

Ann Surg 2006 Feb;243(2):273-80

Department of Surgery, Yale University School of Medicine, New Haven, CT 06520-8062, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.sla.0000197734.28551.0fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448909PMC
February 2006

The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia.

Ann Surg Oncol 2006 Feb 20;13(2):253-62. Epub 2006 Jan 20.

Department of Surgery, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208062, New Haven, Connecticut 06520-8062, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/ASO.2006.12.011DOI Listing
February 2006

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

J Clin Oncol 2006 Feb 9;24(5):736-47. Epub 2006 Jan 9.

Department of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.00.3335DOI Listing
February 2006

Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.

J Natl Cancer Inst 2005 Dec;97(24):1808-15

Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dji427DOI Listing
December 2005

Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer.

Clin Cancer Res 2005 Dec;11(24 Pt 1):8637-43

Department of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-1436DOI Listing
December 2005

Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome.

Cancer Epidemiol Biomarkers Prev 2005 Nov;14(11 Pt 1):2517-23

Department of Pathology, Yale University School of Medicine, 310 Cedar Street, New Haven, CT 06520-8023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-05-0464DOI Listing
November 2005

Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.

Clin Cancer Res 2005 Jul;11(14):5188-94

Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-05-0158DOI Listing
July 2005

Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.

Clin Cancer Res 2005 Jun;11(11):4083-9

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-2191DOI Listing
June 2005

Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.

Clin Cancer Res 2005 Feb;11(3):1160-6

Department of Otolaryngology, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
February 2005

Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.

Cancer 2005 Jan;103(2):229-36

Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8062, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.20750
Publisher Site
http://dx.doi.org/10.1002/cncr.20750DOI Listing
January 2005

Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.

Cancer Res 2004 Dec;64(23):8773-7

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-1387DOI Listing
December 2004

Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.

Cancer Res 2004 Dec;64(23):8767-72

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-1384DOI Listing
December 2004

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Clin Cancer Res 2004 Nov;10(21):7252-9

Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-0713DOI Listing
November 2004

Long-term preservation of antigenicity on tissue microarrays.

Lab Invest 2004 Aug;84(8):1071-8

Department of Pathology, Yale University, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/3700131
Publisher Site
http://dx.doi.org/10.1038/labinvest.3700131DOI Listing
August 2004

Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study.

Melanoma Res 2004 Jun;14(3):207-10

Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cmr.0000130874.33504.2fDOI Listing
June 2004

beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.

Cancer 2004 May;100(10):2084-92

Section of Medical Oncology, Yale Cancer Center, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20232DOI Listing
May 2004

Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.

Clin Cancer Res 2004 Jan;10(1 Pt 1):173-7

Departments of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.ccr-0699-3DOI Listing
January 2004

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.

J Clin Oncol 2003 Sep;21(17):3226-35

Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.10.130DOI Listing
September 2003

Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.

Cancer Res 2003 Apr;63(7):1445-8

Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
April 2003

Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome.

Int J Cancer 2003 Feb;103(5):652-6

Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.10893DOI Listing
February 2003

Automated subcellular localization and quantification of protein expression in tissue microarrays.

Nat Med 2002 Nov 21;8(11):1323-7. Epub 2002 Oct 21.

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm791DOI Listing
November 2002

Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.

Cancer Res 2002 Jan;62(2):497-505

Division of Medical Oncology, Department of Internal Medicine, The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903, USA.

View Article

Download full-text PDF

Source
January 2002

RET activation and clinicopathologic features in poorly differentiated thyroid tumors.

J Clin Endocrinol Metab 2002 Jan;87(1):370-9

Centro di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, 80131 Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jcem.87.1.8174DOI Listing
January 2002